Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sensus Healthcare, Inc.SRTS · Entity 7142 | Director · CHIEF EXECUTIVE OFFICER | August 20, 2026 | August 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sensus Healthcare, Inc.
Report date August 20, 2026 · Filed August 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,220,293 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Purchase · Acquired 20,000 · Balance 1,220,293 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 20, 2026 Filed Aug 24, 2026 20:00 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | PurchaseCommon Stock | 20,000 | $3.02 | $60,486.00 |
DisclosureSEC source: 0001300111-26-000002 · form4-08242026_080806.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220,293 Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 14:34 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | PurchaseCommon Stock | 25,000 | $4.03 | $100,750.00 |
DisclosureSEC source: 0001300111-25-000005 · form4-11192025_021106.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200,293 F1 · price: Represents the average price per share. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 15:04 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | PurchaseCommon Stock | 10,000 | $2.88 | $28,773.00 |
DisclosureSEC source: 0001415889-23-013321 · form4-09182023_030948.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,175,293 F1 · price: Represents the average price per share. Read SEC document |
| August 08, 2023 Filed Aug 8, 2023 18:43 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | PurchaseCommon Stock | 10,000 | $3.86 | $38,574.00 |
DisclosureSEC source: 0001415889-23-011917 · form4-08082023_060824.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,165,293 F1 · price: Represents the average price per share. Read SEC document |
| May 10, 2023 Filed May 11, 2023 14:14 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | PurchaseCommon Stock | 7,925 | $3.00 | $23,735.38 |
DisclosureSEC source: 0001415889-23-007766 · form4-05112023_020512.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,155,293 F1 · price: Represents the average price per share. Read SEC document |
| May 09, 2023 Filed May 11, 2023 14:14 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | PurchaseCommon Stock | 17,075 | $2.99 | $51,055.96 |
DisclosureSEC source: 0001415889-23-007766 · form4-05112023_020512.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,147,368 F1 · price: Represents the average price per share. Read SEC document |
| September 07, 2022 Filed Sep 7, 2022 20:41 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 15,794 | $12.58 | $198,642.72 |
DisclosureSEC source: 0001300111-22-000001 · primary_doc.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,130,293 F3 · price: This represents the average price per share. The shares were sold at prices ranging from $12.54 to $12.70. Read SEC document |
| September 06, 2022 Filed Sep 7, 2022 20:41 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 15,794 | $12.56 | $198,446.87 |
DisclosureSEC source: 0001300111-22-000001 · primary_doc.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,087 F2 · price: This represents the average price per share. The shares were sole at prices ranging from $12.50 to $12.61. Read SEC document |
| September 02, 2022 Filed Sep 7, 2022 20:41 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 10,000 | $12.42 | $124,168.00 |
DisclosureSEC source: 0001300111-22-000001 · primary_doc.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161,881 F1 · price: This represents the average price per share. The shares were sold at prices ranging from $12.40 to $12.47. Read SEC document |
| August 11, 2022 Filed Aug 11, 2022 20:58 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 28,999 | $14.21 | $412,217.89 |
DisclosureSEC source: 0001415889-22-008495 · form4-08112022_010832.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,171,881 F3 · price: This represents the average price per share. The shares were sold from prices ranging from $13.76 to $14.37. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 20:58 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 93,320 | $14.16 | $1,321,196.56 |
DisclosureSEC source: 0001415889-22-008495 · form4-08112022_010832.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200,880 F2 · price: This represents the average price per share. The shares were sold from prices ranging from $14 to $14.48. Read SEC document |
| August 09, 2022 Filed Aug 11, 2022 20:58 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 36,093 | $13.97 | $504,064.01 |
DisclosureSEC source: 0001415889-22-008495 · form4-08112022_010832.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,294,200 F1 · price: This represents the average price per share. The shares were sold from prices ranging from $13.92 to $14.132. Read SEC document |
| March 11, 2022 Filed Mar 11, 2022 21:52 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 44,782 | $10.11 | $452,643.02 |
DisclosureSEC source: 0001415889-22-002898 · form4-03112022_010341.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,330,293 F3 · price: This represents the average price per share. The shares were sold from prices ranging from $10.05 to $10.23. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 21:52 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 38,300 | $10.18 | $389,932.30 |
DisclosureSEC source: 0001415889-22-002898 · form4-03112022_010341.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375,075 F2 · price: This represents the average price per share. The shares were sold from prices ranging from $10.05 to $10.29. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:52 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 50,274 | $10.19 | $512,206.59 |
DisclosureSEC source: 0001415889-22-002898 · form4-03112022_010341.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,375 F1 · price: This represents the average price per share. The shares were sold from prices ranging from $10.05 to $10.55. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 18:48 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 10,926 | $7.02 | $76,676.48 |
DisclosureSEC source: 0001415889-21-006059 · form4-12172021_101201.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,463,649 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F3 · price: The sale prices range from $6.85 through $7.25. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 18:48 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 13,301 | $6.99 | $92,962.02 |
DisclosureSEC source: 0001415889-21-006059 · form4-12172021_101201.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,575 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F2 · price: The sale prices range from $6.85 through $7.45. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 20:42 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 13,969 | $7.22 | $100,824.05 |
DisclosureSEC source: 0001415889-21-005956 · form4-12152021_121241.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,492,479 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F2 · price: The sale prices range from $6.86 through $7.46. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:56 UTC Amendment | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 13,969 | $7.22 | $100,824.05 |
DisclosureSEC source: 0001415889-21-006035 · form4a-12162021_011245.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,487,876 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F3 · price: The sale prices range from $6.86 through $7.46. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 21:56 UTC Amendment | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,603 | $6.98 | $32,132.62 |
DisclosureSEC source: 0001415889-21-006035 · form4a-12162021_011245.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,501,845 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F2 · price: The sale prices range from $6.78 through $7.40. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 20:10 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 10,271 | $7.78 | $79,895.03 |
DisclosureSEC source: 0001415889-21-005838 · form4-12132021_121218.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,506,448 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F3 · price: The sale prices range from $7.58 through $7.885. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 20:10 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 21,930 | $7.79 | $170,893.91 |
DisclosureSEC source: 0001415889-21-005838 · form4-12132021_121218.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,516,719 F1 · kind: These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934. F2 · price: The sale prices range from $7.35 through $7.98. Read SEC document |
| September 11, 2018 Filed Sep 13, 2018 01:29 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,052 | $7.51 | $7,900.52 |
DisclosureSEC source: 0001415889-18-001376 · form4-09122018_060934.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538,649 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F3 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.53. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 10, 2018 Filed Sep 13, 2018 01:29 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,857 | $7.55 | $14,020.35 |
DisclosureSEC source: 0001415889-18-001376 · form4-09122018_060934.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,539,701 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.56. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 29, 2018 Filed Aug 30, 2018 20:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 322 | $7.50 | $2,415.00 |
DisclosureSEC source: 0001415889-18-001308 · form4-08302018_010849.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541,558 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 28, 2018 Filed Aug 30, 2018 20:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 1,166 | $7.50 | $8,745.00 |
DisclosureSEC source: 0001415889-18-001308 · form4-08302018_010849.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541,880 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,803 | $7.50 | $21,022.50 |
DisclosureSEC source: 0001415889-18-001250 · form4-08102018_010829.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,543,046 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 20:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 3,367 | $7.50 | $25,252.50 |
DisclosureSEC source: 0001415889-18-001250 · form4-08102018_010829.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,849 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 19:56 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 350 | $7.50 | $2,625.00 |
DisclosureSEC source: 0001415889-18-001223 · form4-08062018_120850.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,549,216 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:03 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 754 | $7.50 | $5,655.00 |
DisclosureSEC source: 0001415889-18-001059 · form4-06282018_020631.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,549,566 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 23:20 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 10,854 | $7.52 | $81,622.08 |
DisclosureSEC source: 0001415889-18-001024 · form4-06252018_040605.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550,320 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:20 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,865 | $7.52 | $36,584.80 |
DisclosureSEC source: 0001415889-18-001024 · form4-06252018_040605.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,561,174 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 22:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 7,945 | $7.52 | $59,746.40 |
DisclosureSEC source: 0001415889-18-000977 · form4-06202018_030637.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,566,039 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,365 | $7.57 | $33,043.05 |
DisclosureSEC source: 0001415889-18-000977 · form4-06202018_030637.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573,984 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 22:22 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 9,352 | $7.52 | $70,327.04 |
DisclosureSEC source: 0001415889-18-000977 · form4-06202018_030637.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,578,349 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 16:40 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 6,953 | $6.00 | $41,718.00 |
DisclosureSEC source: 0001615774-17-006048 · s107936_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587,701 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.01. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| September 13, 2017 Filed Sep 19, 2017 18:05 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 3,512 | $6.00 | $21,072.00 |
DisclosureSEC source: 0001615774-17-005191 · s107549_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,594,654 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 18:52 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,595 | $6.00 | $15,570.00 |
DisclosureSEC source: 0001615774-17-005052 · s107488_form4.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,598,166 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 08, 2017 Filed Sep 13, 2017 18:52 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,990 | $6.00 | $29,940.00 |
DisclosureSEC source: 0001615774-17-005052 · s107488_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600,761 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 07, 2017 Filed Sep 13, 2017 18:52 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,607 | $6.00 | $27,642.00 |
DisclosureSEC source: 0001615774-17-005052 · s107488_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605,751 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 23:37 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 3,741 | $6.00 | $22,446.00 |
DisclosureSEC source: 0001615774-17-004955 · s107422_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610,358 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 23:37 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 9,579 | $6.00 | $57,474.00 |
DisclosureSEC source: 0001615774-17-004955 · s107422_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614,099 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.05. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 19:32 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 2,143 | $6.00 | $12,858.00 |
DisclosureSEC source: 0001615774-17-004826 · s107371_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,623,678 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 19:32 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 7,482 | $6.00 | $44,892.00 |
DisclosureSEC source: 0001615774-17-004826 · s107371_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,625,821 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.02. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 18:48 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 4,588 | $6.00 | $27,528.00 |
DisclosureSEC source: 0001615774-17-004750 · s107342_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633,303 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 18:48 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 3,579 | $6.00 | $21,474.00 |
DisclosureSEC source: 0001615774-17-004750 · s107342_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,637,891 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016. Read SEC document |
| December 02, 2016 Filed Dec 5, 2016 23:23 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 166 | $6.00 | $996.00 |
DisclosureSEC source: 0001615774-16-008722 · s104869_sardano.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641,470 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 01, 2016 Filed Dec 5, 2016 23:23 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 108 | $6.00 | $648.00 |
DisclosureSEC source: 0001615774-16-008722 · s104869_sardano.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641,636 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 23:06 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 520 | $6.00 | $3,120.00 |
DisclosureSEC source: 0001615774-16-008667 · s104834_form4.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,641,744 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 29, 2016 Filed Dec 1, 2016 23:06 UTC | Sensus Healthcare, Inc. SRTS · Entity 7142 | SaleCommon Stock | 404 | $6.00 | $2,424.00 |
DisclosureSEC source: 0001615774-16-008667 · s104834_form4.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,642,264 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.